InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Snell Kristi, Director. Director active across 1 company, notably YIELD10 BIOSCIENCE, INC.. Cumulatively, 8 disclosures have been recorded. Activity tracked since 1 September 2021. The latest transaction was filed on 15 August 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
877 shares@ US$1.501.7% of flowCommon StockSEC:0001628280-24-037879:0
120,000 shares@ US$0.3048.3% of flowCommon StockSEC:0001628280-24-005491:0
1,177 shares@ US$3.595.7% of flowCommon StockSEC:0001687986-23-000005:0
988 shares@ US$2.683.7% of flowCommon StockSEC:0001104659-22-089862:0
418 shares@ US$4.255.6% of flowCommon StockSEC:0001104659-22-030198:0
6,733 shares@ US$3.8380.2% of flowCommon StockSEC:0001179110-22-001145:0
351 shares@ US$6.717.1% of flowCommon StockSEC:0001179110-21-008612:0
351 shares@ US$6.712.9% of flowCommon StockSEC:0001179110-21-008612
8 of 8 declarations
About Snell Kristi
Kristi Snell is VP of Research and Chief Scientific Officer at YIELD10 BIOSCIENCE, INC. She oversees research operations and contributes to the company's innovation strategy. Her scientific expertise is essential for the development of new products.
